Releases - Elekta

View:
 

Found press releases

 

Elekta to focus on continued strong growth and R&D investments in coming years

6/12/2013 7:00 AM EST
STOCKHOLM, Sweden, June 12 – Following on a strong year-end report, Elekta presented a very positive outlook for the coming years at its Capital Markets Day in Stockholm.
Elekta President and CEO, Tomas Puusepp, opened the meeting by presenting statistics that support Elekta’s stronger position in all markets and he restated the company’s ambition of two million patients being treated with Elekta solutions...

Elekta-Equra Health Partnership to Increase South African Cancer Patients’ Acces...

6/10/2013 1:30 AM EST
Agreement includes 15 linear accelerators, oncology information systems and joint-venture training facility
CAPE TOWN and STOCKHOLM, June 10 – To address the growing need for radiation therapy services in South Africa, Equra Health (Cape Town) has entered into a long-term agreement with Elekta in which Equra will acquire 15 Elekta radiation therapy systems and allied equipment. Equra and Elekta also will work...

Year-end report May – April 2012/13

6/5/2013 1:30 AM EST

· Order bookings increased 14* percent to SEK 12,117 M (10,815).
· Net sales increased 16* percent to SEK 10,339 M (9,048).
· Operating result amounted to SEK 2,058 M (1,837) excluding non-recurring items of SEK -46 M (12).
· Net income amounted to SEK 1,351 M (1,228). Earnings per share amounted to SEK 3.52 (3.26) before dilution and SEK 3.52 (3.23) after dilution.
· Cash flow after continuous investments was...

Number of outstanding shares in Elekta AB (publ)

5/31/2013 12:00 PM EST
Stockholm, May 31, 2013 – The total number of shares in Elekta as of May 31, 2013, amounts to 382,824,093 divided between 14,250,000 A shares and 368,574,093 B shares.
The increase of 77 new B shares is attributable to the conversion of shares within the framework of the 2012/17 convertible bond.

One A share entitles the holder to ten votes and one B share to one vote.

# # #

For further information, please...

Reminder – Elekta’s Capital Markets Day in Stockholm on June 12, 2013

5/28/2013 1:30 AM EST
Stockholm, May 28, 2013

Elekta invites equity analysts, investors and media representatives to Elekta’s Capital Markets Day on June 12 at Clarion Sign Hotel in Stockholm. Presentations will start at 13:00 CET and end approximately 16:00 CET. Lunch will be served from 12:15 CET.
Tomas Puusepp, President and CEO, and other members of Elekta’s management team will give presentations focusing on Elekta’s strategy...

Leeds’ St James’s Institute of Oncology Acquires Two Elekta Versa HD Radiotherap...

5/27/2013 1:30 AM EST
Revolutionary technology enables higher quality cancer care for patients in Yorkshire
LEEDS, England, May 27 – St James's Institute of Oncology, a leading radiotherapy center in the UK, recently ordered two Versa HD™ systems, an advanced linear accelerator designed to improve patient care and treat a wide range of tumors throughout the body. As the latest, most sophisticated cancer treatment system on the...

Elekta Nomination Committee’s proposals for the 2013 Annual General Meeting

5/21/2013 1:30 AM EST
Stockholm, May 21 – The Nomination Committee of Elekta AB (publ) proposes that the 2013 Annual General Meeting elects Laurent Leksell as the new Chairman of the Board. Akbar Seddigh, who has been Chairman of the Board since 1999 and a Board member since 1998, has declined re-election. Laurent Leksell, who is the company’s largest shareholder, has been a Board member since 1972 and was the company’s President and CEO...

Conference call regarding Elekta’s 2012/13 Full Year Report

5/10/2013 3:00 AM EST
Stockholm, May 10, 2013

Elekta will publish its 2012/13 Full Year Report on June 5 as per:

· The report will be published at 07.30 CET.
· Elekta will host a telephone conference at 10:00-11:00 CET with Tomas Puusepp, President and CEO and Håkan Bergström, CFO.
To take part in the conference call, please dial in about five minutes in advance and use the access code 931950.

· UK dial-in number: +44 20...

Canada’s Sunnybrook Health Sciences Centre Joins Elekta and Philips Research Con...

5/10/2013 1:30 AM EST
Research projects to have implications for cancer treatment worldwide
TORONTO, May 10 – Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that Sunnybrook Health Sciences Centre (Toronto, Canada) will join their growing consortium to validate the clinical potential of MRI-guided radiation therapy.

Sunnybrook Health Sciences Centre, the sixth largest cancer center in North...

Number of outstanding shares in Elekta AB (publ)

4/30/2013 12:00 PM EST
The total number of shares in Elekta as of April 30, 2013, amounts to 382,824,016 divided between 14,250,000 A shares and 368,574,016 B shares.

The increase of 211 new B shares is attributable to the conversion of shares within the framework of the 2012/17 convertible bond.

One A share entitles the holder to ten votes and one B share to one vote.

# # #

For further information, please contact:
Johan Andersson,...

Elekta

RSS

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems ...

View more


  CONTACT  
  • Johan Andersson Melbi
  • Director Investor Relations
  • +46 8 587 25 415
  •